174 related articles for article (PubMed ID: 35521975)
1. Potential drug-drug interactions between antiretroviral drugs and comedications, including dietary supplements, among people living with HIV: A clinical survey.
Tinggaard M; David KP; Gerstoft J; Hansen AE; Kirk O; Lebech AM; Lindhardt BØ; Rose MV; Ryom L; Weis N; Benfield T
HIV Med; 2023 Jan; 24(1):46-54. PubMed ID: 35521975
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of Polypharmacy and Potential Drug-Drug Interactions Associated with Risk Factors in the Era of HIV Integrase Inhibitors: A Prospective Clinical Study.
Altunal LN; Yagcı Caglayık D; Ozel AS; Tukenmez Tigen E; Sili U; Erturk Sengel B; Aydın M; Korten V
AIDS Patient Care STDS; 2023 Mar; 37(3):138-145. PubMed ID: 36812461
[TBL] [Abstract][Full Text] [Related]
3. A retrospective study: Can dual ART mitigate the risk of potential drug-drug interactions among PLWH under stable ART?
Inkaya AÇ; Balli FN; Kara E; Demirkan K; Ünal S
Turk J Med Sci; 2023; 53(5):1505-1511. PubMed ID: 38813033
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of comedications and effect of potential drug-drug interactions in the Swiss HIV Cohort Study.
Marzolini C; Elzi L; Gibbons S; Weber R; Fux C; Furrer H; Chave JP; Cavassini M; Bernasconi E; Calmy A; Vernazza P; Khoo S; Ledergerber B; Back D; Battegay M;
Antivir Ther; 2010; 15(3):413-23. PubMed ID: 20516560
[TBL] [Abstract][Full Text] [Related]
5. Polypharmacy and drug-drug interactions in older and younger people living with HIV: the POPPY study.
Halloran MO; Boyle C; Kehoe B; Bagkeris E; Mallon P; Post FA; Vera J; Williams I; Anderson J; Winston A; Sachikonye M; Sabin C; Boffito M
Antivir Ther; 2019; 24(3):193-201. PubMed ID: 30700636
[TBL] [Abstract][Full Text] [Related]
6. Concurrent use of comedications reduces adherence to antiretroviral therapy among HIV-infected patients.
Cantudo-Cuenca MR; Jiménez-Galán R; Almeida-Gonzalez CV; Morillo-Verdugo R
J Manag Care Spec Pharm; 2014 Aug; 20(8):844-50. PubMed ID: 25062078
[TBL] [Abstract][Full Text] [Related]
7. Burden of Exposure to Potential Interactions Between Antiretroviral and Non-Antiretroviral Medications in a Population of HIV-Positive Patients Aged 50 Years or Older.
Ranzani A; Oreni L; Agrò M; van den Bogaart L; Milazzo L; Giacomelli A; Cattaneo D; Gervasoni C; Ridolfo AL
J Acquir Immune Defic Syndr; 2018 Jun; 78(2):193-201. PubMed ID: 29767640
[TBL] [Abstract][Full Text] [Related]
8. Frequency and severity of potential drug interactions in a cohort of HIV-infected patients Identified through a Multidisciplinary team.
Molas E; Luque S; Retamero A; Echeverría-Esnal D; Guelar A; Montero M; Guerri R; Sorli L; Lerma E; Villar J; Knobel H
HIV Clin Trials; 2018 Feb; 19(1):1-7. PubMed ID: 29179644
[TBL] [Abstract][Full Text] [Related]
9. Use of comedications and potential drug-drug interactions in people living with HIV in China.
Chen R; Chen J; Tang Q; Meng Z; Luo L; Zhang W; Deng A; Zhang L; Wang J; Qi T; Zhang R; Shen Y; Liu L; Steinhart C; Lu H
J Infect Chemother; 2020 Jul; 26(7):722-728. PubMed ID: 32354599
[TBL] [Abstract][Full Text] [Related]
10. Comorbidities and the use of comedications in people living with HIV on antiretroviral therapy in Japan: a cross-sectional study using a hospital claims database.
Ruzicka DJ; Imai K; Takahashi K; Naito T
BMJ Open; 2018 Jun; 8(6):e019985. PubMed ID: 29903786
[TBL] [Abstract][Full Text] [Related]
11. Prevalence, beliefs and impact of drug-drug interactions between antiretroviral therapy and illicit drugs among people living with HIV in Spain.
Castro-Granell V; Garin N; Jaén Á; Cenoz S; Galindo MJ; Fuster-RuizdeApodaca MJ
PLoS One; 2021; 16(11):e0260334. PubMed ID: 34797882
[TBL] [Abstract][Full Text] [Related]
12. Changes in Prescription and Over-the-Counter Medication and Dietary Supplement Use Among Older Adults in the United States, 2005 vs 2011.
Qato DM; Wilder J; Schumm LP; Gillet V; Alexander GC
JAMA Intern Med; 2016 Apr; 176(4):473-82. PubMed ID: 26998708
[TBL] [Abstract][Full Text] [Related]
13. Factors associated with polypharmacy and the prescription of multiple medications among persons living with HIV (PLWH) compared to non-PLWH.
Moore HN; Mao L; Oramasionwu CU
AIDS Care; 2015; 27(12):1443-8. PubMed ID: 26608408
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of Potential Drug-drug Interactions With Ritonavir-containing COVID-19 Therapy in the United States: An Analysis of the National Health and Nutrition Examination Survey.
Igho-Osagie E; Brzozowski K; Jin H; Brown J; Williams MG; Puenpatom A
Clin Ther; 2023 May; 45(5):390-399.e4. PubMed ID: 37032225
[TBL] [Abstract][Full Text] [Related]
15. Polypharmacy and potential drug-drug interactions among people living with HIV in the era of integrase strand transfer inhibitor-based antiretroviral therapy.
Peng AT; Huang SH; Lee HY; Wu PY; Kuo HY; Hung CC
Int J Antimicrob Agents; 2024 Feb; 63(2):107067. PubMed ID: 38141835
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of polypharmacy, polyherbacy, nutritional supplement use and potential product interactions among older adults living on the United States-Mexico border: a descriptive, questionnaire-based study.
Loya AM; González-Stuart A; Rivera JO
Drugs Aging; 2009; 26(5):423-36. PubMed ID: 19552494
[TBL] [Abstract][Full Text] [Related]
17. Association of age with polypharmacy and risk of drug interactions with antiretroviral medications in HIV-positive patients.
Tseng A; Szadkowski L; Walmsley S; Salit I; Raboud J
Ann Pharmacother; 2013 Nov; 47(11):1429-39. PubMed ID: 24285760
[TBL] [Abstract][Full Text] [Related]
18. Polypharmacy and Aging in People Living with HIV: 6 Years of Experience in a Multidisciplinary Outpatient Clinic.
Cattaneo D; Oreni L; Meraviglia P; Minisci D; Astuti N; Antinori S; Gori A; Gervasoni C
Drugs Aging; 2023 Jul; 40(7):665-674. PubMed ID: 37310576
[TBL] [Abstract][Full Text] [Related]
19. Co-medications and Drug-Drug Interactions in People Living with HIV in Turkey in the Era of Integrase Inhibitors.
Yeşilbağ Z; Şengül Eİ; Şenoğlu S; Aydın ÖA; Karaosmanoğlu HK
Curr HIV Res; 2020; 18(6):415-425. PubMed ID: 32787762
[TBL] [Abstract][Full Text] [Related]
20. Polypharmacy and risk of non-fatal overdose for patients with HIV infection and substance dependence.
Kim TW; Walley AY; Heeren TC; Patts GJ; Ventura AS; Lerner GB; Mauricio N; Saitz R
J Subst Abuse Treat; 2017 Oct; 81():1-10. PubMed ID: 28847449
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
